Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
American Journal of Therapeutics
|
April 17, 2001
Cox-2-specific inhibitors: definition of a new therapeutic concept
K M Verburg, T J Maziasz, E Weiner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1981
Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses
S A Anderson, P C Isakson, E Puré, et al.
The Journal of Experimental Medicine
|
February 1, 1983
T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice
E Pure, P C Isakson, J W Kappler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1989
Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line
L Simpson, I McNiece, M Newberg, et al.
Journal of Clinical Pharmacology
|
February 9, 2000
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial
P T Leese, R C Hubbard, A Karim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 7, 2001
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1
T L Yaksh, D M Dirig, C M Conway, et al.
Federation Proceedings
|
November 1, 1976
Angiotensin antogonists as pharmacological tools
P Needleman, J R Douglas, B A Jakschik, et al.
Archives of Internal Medicine
|
May 29, 2000
Effects of celecoxib and naproxen on renal function in the elderly
A Whelton, G Schulman, C Wallemark, et al.
The Journal of Clinical Investigation
|
June 1, 1996
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
G D Anderson, S D Hauser, K L McGarity, et al.
Journal of the National Cancer Institute
|
April 1, 1981
Increased susceptibility to lethal effects of bacterial lipopolysaccharide in mice with B-cell leukemia
M J Muirhead, E S Vitetta, P C Isakson, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
American Journal of Therapeutics
|
April 17, 2001
Cox-2-specific inhibitors: definition of a new therapeutic concept
K M Verburg, T J Maziasz, E Weiner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1981
Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses
S A Anderson, P C Isakson, E Puré, et al.
The Journal of Experimental Medicine
|
February 1, 1983
T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice
E Pure, P C Isakson, J W Kappler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1989
Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line
L Simpson, I McNiece, M Newberg, et al.
Journal of Clinical Pharmacology
|
February 9, 2000
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial
P T Leese, R C Hubbard, A Karim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 7, 2001
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1
T L Yaksh, D M Dirig, C M Conway, et al.
Federation Proceedings
|
November 1, 1976
Angiotensin antogonists as pharmacological tools
P Needleman, J R Douglas, B A Jakschik, et al.
Archives of Internal Medicine
|
May 29, 2000
Effects of celecoxib and naproxen on renal function in the elderly
A Whelton, G Schulman, C Wallemark, et al.
The Journal of Clinical Investigation
|
June 1, 1996
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
G D Anderson, S D Hauser, K L McGarity, et al.
Journal of the National Cancer Institute
|
April 1, 1981
Increased susceptibility to lethal effects of bacterial lipopolysaccharide in mice with B-cell leukemia
M J Muirhead, E S Vitetta, P C Isakson, et al.
Page
of 10